PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

BACKGROUND: Vaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life. However, there is still considerable overtreatment and als...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Gynecol Cancer
Autori principali: van den Heerik, Anne Sophie V M, Horeweg, Nanda, Nout, Remi A, Lutgens, Ludy C H W, van der Steen-Banasik, Elzbieta M, Westerveld, G Henrike, van den Berg, Hetty A, Slot, Annerie, Koppe, Friederike L A, Kommoss, Stefan, Mens, Jan Willem M, Nowee, Marlies E, Bijmolt, Stefan, Cibula, David, Stam, Tanja C, Jurgenliemk-Schulz, Ina M, Snyers, An, Hamann, Moritz, Zwanenburg, Aleida G, Coen, Veronique L M A, Vandecasteele, Katrien, Gillham, Charles, Chargari, Cyrus, Verhoeven-Adema, Karen W, Putter, Hein, van den Hout, Wilbert B, Wortman, Bastiaan G, Nijman, Hans W, Bosse, Tjalling, Creutzberg, Carien L
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Clinical Trial
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788476/
https://ncbi.nlm.nih.gov/pubmed/33046573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2020-001929
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi